NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-007-2015-0-GB-10 CD47-targeted Therapies For The Treatment Of Infectious Disease GB EP 14748994.2 Issued
NIAID E-007-2015-0-NL-12 CD47-targeted Therapies For The Treatment Of Infectious Disease NL EP 14748994.2 Issued
NIAID E-007-2015-0-IE-15 CD47-targeted Therapies For The Treatment Of Infectious Disease IE EP 14748994.2 Abandoned
NIAID E-007-2015-0-IT-11 CD47-targeted Therapies For The Treatment Of Infectious Disease IT EP 14748994.2 Issued
NIAID E-007-2015-0-EP-04 CD47-targeted Therapies For The Treatment Of Infectious Disease EP National Stage 14748994.2 Issued
NIAID E-007-2015-0-PCT-02 CD47-targeted Therapies For The Treatment Of Infectious Disease PCT PCT PCT/US2014/014905 Expired
NIAID E-007-2015-0-HK-01 CD47-targeted Therapies For The Treatment Of Infectious Disease HK EP 42023073368.5 Pending
NCI E-090-2014-0-US-01 Novel natural-product-based nitrogen-containing anti-cancer agents US 61/936,285 Abandoned
NIAID E-189-2011-2-US-05 Treatment and Prevention of Diseases Mediated by Microorganisms via Drug-Mediated Manipulation of the Eicosanoid Balance US National Stage 14/236,940 Abandoned
NCI E-234-2014-0-US-01 Methods For Producing Autologous T Cells Useful To Treat B Cell Malignancies And Other Cancers US 61/935,833 Abandoned
NHLBI E-074-2014-0-US-01 Real-Time Processing Of Medical Imaging Raw Data Using Cloud Computing US 61/934,987 Abandoned
NCI E-004-2005-4-AU-06 Human Monoclonal Antibodies Against Hendra And Nipah AU DIV 2014200581 Abandoned
NEI E-251-2012-3-CA-05 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) CA National Stage 2899865 Issued
NEI E-251-2012-3-AU-06 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) AU National Stage 2014212230 Issued
NEI E-251-2012-3-JP-07 Method For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) JP National Stage 2015-556170 Issued
NEI E-251-2012-3-NL-13 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) NL EP 14705645.1 Issued
NEI E-251-2012-3-DK-08 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) DK EP 14705645.1 Issued
NEI E-251-2012-3-IE-12 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) IE EP 14705645.1 Issued
NEI E-251-2012-3-DE-11 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) DE EP 14705645.1 Issued
NEI E-251-2012-3-FI-09 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) FI EP 14705645.1 Issued
NEI E-251-2012-3-FR-10 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) FR EP 14705645.1 Issued
NEI E-251-2012-3-EP-04 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) EP National Stage 14705645.1 Issued
NEI E-251-2012-3-GB-14 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) GB EP 14705645.1 Issued
NIAID E-202-2011-1-US-06 Protease-Deficient Bacillus Anthracis US National Stage 14/236,430 9555064 Issued PDF
NEI E-251-2012-3-PCT-02 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) PCT PCT PCT/US2014/014160 Expired
NIMH E-036-2013-0-PCT-02 Retroviral Vector Packaging Cell Lines and Methods of Purifying and Producing Retroviral Particles PCT PCT PCT/US2014/014013 Expired
NHGRI E-272-2008-0-US-06 USE OF ERBB4 AS A PROGNOSTIC AND THERAPEUTIC MARKER FOR MELANOMA US DIV 14/169,602 Abandoned
NEI E-251-2012-3-EP-15 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) EP DIV 17197785.3 Abandoned
NEI E-251-2012-3-JP-17 Method For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) JP DIV 2018-200003 Abandoned
NCI E-019-2014-1-US-01 Compounds that Bind to Human Immunodeficiency Virus Rev Response Element US 61/934,379 Abandoned
NCI E-293-2010-0-US-03 Lipopeptide Inhibitors Of RAS Oncoprotein US National Stage 14/119,596 9328142 Issued PDF
NCI E-027-2014-0-US-01 4-Benzyl-Amino-Benzyl-Alcohol Anti-Cancer Agents US 61/933,606 Abandoned
NCI E-070-2013-0-US-02 MICROFABRICATED POLYMERIC VESSEL MIMETICS US ORD 14/166,744 9670447 Issued PDF
NCI E-285-2006-2-AU-07 DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS AU DIV 2014200453 Issued
NCI E-227-2014-0-US-01 Combination Of Griffithsin With Other Substances To Make A Product For The Prevention Of STD US 61/932,706 Abandoned
NCI E-055-2014-0-US-01 Anti-NY-BR-1 Polypeptides, Proteins, and Chimeric Antigen Receptors US 61/931,095 Abandoned
NCI E-020-2013-0-EP-03 Compositions and Methods for Detecting Neoplasia EP National Stage 14704237.8 Abandoned
NCI E-020-2013-0-GB-07 Compositions and Methods for Detecting Neoplasia GB EP 14704237.8 Abandoned
NCI E-020-2013-0-DE-05 Compositions and Methods for Detecting Neoplasia DE EP 14704237.8 Abandoned
NCI E-020-2013-0-FR-06 Compositions and Methods for Detecting Neoplasia FR EP 14704237.8 Abandoned
NCI E-020-2013-0-PCT-02 Compositions and Methods for Detecting Neoplasia PCT PCT PCT/US2014/012758 Expired
NHGRI E-039-2014-0-US-01 Compounds and Method for Treating PARP1-Deficient Cancers US 61/930,291 Abandoned
NIDDK E-761-2013-0-US-01 cGAP-PNA MULTIVALENT PEPTIDE NUCLEIC ACID LIGAND DISPLAY US 61/929,893 Abandoned
NIA E-279-2013-0-US-01 METHOD FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS US 61/929,659 Abandoned
NCI E-162-2009-0-AU-08 Pharmaceutical Compositions which Inhibit Of FKBP52-Mediated Regulation Of Androgen Receptor Function And Methods of Using Same AU DIV 2014200360 Abandoned
NCI E-117-2011-0-US-22 Recombinant Immunotoxin Targeting Mesothelin US National Stage 14/115,131 10683362 Issued PDF
NCI E-168-2011-0-US-07 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology US National Stage 14/233,582 9764022 Issued PDF
NCI E-168-2011-0-JP-06 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology JP National Stage 2014-521716 Issued
NIAID E-133-2012-0-PCT-02 Attenuated Chlamydia Vaccine PCT PCT PCT/US2014/011799 Expired
NICHD E-304-2008-0-US-03 Vaccine Against Influenza Virus US DIV 14/157,417 Abandoned